Advanced search
Publication Cover
Expert Review of Clinical Pharmacology Volume 14, 2021 - Issue 2
Submit an article Journal homepage
147
Views
7
CrossRef citations to date
0
Altmetric
Original Research

Radical metastasectomy followed by sorafenib versus observation in patients withclear cell renal cell carcinoma: extended follow -up of efficacy results from the randomized phase II RESORT trial

A. Mennittoa Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, ItalyCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-3665-3295View further author information
ORCID Icon,
E. Verzonia Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, ItalyORCID Iconhttps://orcid.org/0000-0001-9756-6112View further author information
ORCID Icon,
F. Cognettib Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, ItalyView further author information
,
R. Micelic Department of Clinical Epidemiology and Trial Organization, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, ItalyORCID Iconhttps://orcid.org/0000-0003-0954-375XView further author information
ORCID Icon,
M. Milellad Department of Medicine, Medical Oncology, University and Hospital Trust of Verona, Verona, ItalyView further author information
,
A. Moscae Multidisciplinary Oncology Outpatient Clinic, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, ItalyORCID Iconhttps://orcid.org/0000-0003-2538-8411View further author information
ORCID Icon,
V. E. Chiurif Medical Oncology Department, Ospedale Vito Fazzi, Lecce, ItalyView further author information
,
A. Bearzg Medical Oncology Department, National Cancer Institute, Aviano, ItalyView further author information
,
F. Morellih Medical Oncology Department, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, ItalyORCID Iconhttps://orcid.org/0000-0003-2378-9094View further author information
ORCID Icon,
C. Ortegai Department of Medical Oncology, Ospedale S. Lazzaro ASL CN2 Alba-Bra, Cuneo, ItalyView further author information
,
F. Atzorij Medical Oncology Department, University Hospital, University of Cagliari, Cagliari, ItalyORCID Iconhttps://orcid.org/0000-0002-8211-0363View further author information
ORCID Icon,
M. Doninik Medical Oncology Department, Ospedale di Cremona, Cremona, ItalyView further author information
,
M. Clapsa Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, ItalyORCID Iconhttps://orcid.org/0000-0001-7932-7898View further author information
ORCID Icon,
V. Guadalupia Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, ItalyORCID Iconhttps://orcid.org/0000-0002-3271-2091View further author information
ORCID Icon,
P. Sepea Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, ItalyView further author information
,
V. Cappellettil Biomarker Unit, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale Tumori di Milano, Milan, ItalyORCID Iconhttps://orcid.org/0000-0002-9709-0676View further author information
ORCID Icon,
F. G. de Brauda Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy;m Oncology and Hemato-Oncology Department, University of Milan, Milan, ItalyORCID Iconhttps://orcid.org/0000-0003-0103-730XView further author information
ORCID Icon &
G. Procopioa Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, ItalyORCID Iconhttps://orcid.org/0000-0002-2498-402XView further author information
ORCID Icon show all
Pages 261-268 | Received 26 Sep 2020, Accepted 19 Jan 2021, Published online: 31 Jan 2021

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Achille Bottiglieri, Pierangela Sepe, Marco Stellato, Chiara Pircher, Giuseppe Fotia, Alberto Giovanni Leone, Valentina Guadalupi, Melanie Claps, Patrizia Giannatempo, Elena Verzoni & Giuseppe Procopio. (2022) Optimal Choice of Adjuvant Treatment for Renal Cell Carcinoma Following Nephrectomy. Cancer Management and Research 14, pages 3071-3081.
Read now

Articles from other publishers (6)

C. Aydogdu & J. Casuscelli. (2023) Stellenwert der adjuvanten Systemtherapie beim HochrisikonierenzellkarzinomRole of adjuvant systemic therapy in high-risk renal cell carcinoma. Die Onkologie 29:7, pages 622-631.
Crossref
Jorge Esteban-Villarrubia, Carmen Romero Ferreiro, Lucía Carril-Ajuria, Alberto Carretero-González, Roberto Iacovelli, Laurence Albiges, Daniel Castellano & Guillermo de Velasco. (2023) Meta-analysis of perioperative immunotherapy in renal cell carcinoma: Available, but the jury is still out. Urologic Oncology: Seminars and Original Investigations.
Crossref
Chiara Ciccarese, Alessandro Strusi, Daniela Arduini, Pierluigi Russo, Giuseppe Palermo, Nazario Foschi, Marco Racioppi, Giampaolo Tortora & Roberto Iacovelli. (2023) Post nephrectomy management of localized renal cell carcinoma. From risk stratification to therapeutic evidence in an evolving clinical scenario. Cancer Treatment Reviews 115, pages 102528.
Crossref
Stephanie A. Berg & Bradley A. McGregor. (2022) The Continuing Question of Adjuvant Therapy in Clear Cell Renal Cell Carcinoma. Cancers 14:24, pages 6018.
Crossref
Mark Mikhail, Kevin J. Chua, Labeeqa Khizir, Alexandra Tabakin & Eric A. Singer. (2022) Role of metastasectomy in the management of renal cell carcinoma. Frontiers in Surgery 9.
Crossref
Megan Prunty, Laura Bukavina & Sarah P. Psutka. (2021) Metastasectomy in kidney cancer: current indications and treatment approaches. Current Opinion in Supportive & Palliative Care 15:4, pages 266-275.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.